HIGH QUALITY SERVICE

high technology innovation , high speed development.

HIGH QUALITY SERVICE

上海芯超生物科技有限公司 
生物芯片上海国家工程研究中心

上海市高新技術企業

  • 上海芯超生物科技有限公司成立於2003年12月18日
  • 為美國BIOXXX 組織晶片公司之上游供應商

擁有十五863消化道腫瘤組織庫與組織芯片重大項目、十一五863胰腺癌基因組重大項目、衛生部肝癌組織芯片分子標記物篩選重大項目、863胃癌易感基因與幽門螺桿菌耐藥基因聯合檢測重點項目。

商品介紹

Catalog

Diameter

Dots

Cases

Description

HEsoC050PT01

2.0mm

50

29

29 cases of esophagus squamous cell carcinoma(21 cases tumor with matched NAT, 1 core/case; 8 cases tumor tissue 1 core/case):squamous cell carcinomas,basal cell squamous carcinoma,  spindle cell squamous carcinoma,adenocarcinoma,  adenosquamous carconoma,undifferentiated carcinoma.

HEsoS030PG02

2.0mm

60

30

esophagus squamous cell carcinoma 30 cases: 1 core/case, grade I-Ⅲ.

HEsoS030PG03

2.0mm

30

15

1.Esophagus squamous cell carcinoma (15 cases),  tumor (1 core/case) and matched normal adjacent tissue (1 core/case).   Pathology grade 2.
2.Reproduce of HEso-Squ030PG-01

HEsoS045Ly01

2.0mm

45

15

esophagus squamous cell carcinoma 15 cases, tumor/NAT/lymph node.  Clinical stage

HEsoS060CS01

2.0mm

60

31

2 cases of normal esophageal.Esophagus squamous cell carcinoma 29 cases,tumor and NAT 1 core/case. Clinical stage 1,2,3,4 (Version 7.0).with TNM score.

HEsoS090PG01

1.5mm

90

30

esophagus squamous cell carcinoma 30 cases:tumor/NAT/remote tissue.Pathology grade  I-Ⅲ.

HEsoS180Su04

1.5mm

180

100

1. Esophagus squamous cell carcinoma (100 cases), 80 cases have tumor (1 core/case) and matched normal adjacent tissue (1 core/case). 20 cases have tumor tissue (1 cores/case). 
2. Clinical stage I-Ⅲ(Version 7.0). 
3. Survival information available. Surgery date 2006.7-2008.12, visit date 2014.9. Being followed up for 5.8-7.8 years.
4.duplicate of HEso-Squ180Sur-01

HEsoS180Su06

1.5mm

180

103

203 cases esophagus squamous carcinoma with survival information, 103 cores of tumor and 77 cores of matched NAT.  Surgery date2 011.1-2013.4,visit date 2014.11. Being followed up for 1.6-3.8 years.

HEso-Squ030PG-01

2.0mm

30

15

1. Esophagus squamous cell carcinoma (15 cases), tumor (1 core/case) and matched normal adjacent tissue (1 core/case). 
2.Pathology grade 2

HEso-Squ060CD-01

2.0mm

60

43

1. Progession of Esophageal cancer: normal esophagus mucosa tissue ,esophageal carcinoma in situ, primary focus of esophageal cancer( Clinical stage I-IV),adjacent mucosa tissue, metastases of esophageal cancer, negative lymph node, positive lymph node.
 2. 43 cases, 1 core/case 

HEso-Squ060PG-01

2.0mm

60

30

1. Esophagus squamous cell carcinoma (30 cases), tumor (1 core/case) and matched normal adjacent tissue (1 core/case). 
2. Pathology grade 1 (3 cases), 1-2 (3 cases),  2 (13 cases), 2-3 (3 cases),  3 (8 cases).

HEso-Squ127Lym-01

1.5mm

127

50

1. Esophagus squamous cell carcinoma (50 cases), 27 cases have tumor(1 core/case) and matched normal adjacent tissue (1 core/case) and negative/positive lymph node (1 core/case), 23 cases have tumor tissue (1 core/case) and positive lymph node (1 core/case).  
2.
 Clinical stage N0(10 cases), N1a (20 cases), N1b (12 cases), N2 (4 cases), N3 (4 cases).

HEso-Squ150CS-02

1.5mm

150

75

1.75 cases of  Esophagus squamous cell carcinoma  with matched adjacent normal tissue, 1 core/case.
2.Clinical stage(AJCC 7.0)I  II III  IV, with TNM score.

HEso-Squ172Sur-02

1.5mm

172

93

1. Esophagus squamous cell carcinoma (93 cases),  79 cases have tumor (1 core/case) and matched normal adjacent tissue (1 core/case). 14 cases have tumor tissue (1 core/case). 
2.
 Clinical stage I-Ⅲ (Version 7.0). 
3. Survival information available. 
Surgery date 2009.1-2010.1, visit date 2012.11. Being followed up for 3-4 yeas 

HEso-Squ180Sur-01

1.5mm

180

95

1. Esophagus squamous cell carcinoma (95 cases), 85 cases have tumor (1 core/case) and matched normal adjacent tissue (1 core/case). 10 cases have tumor tissue (1 cores/case). 
2. Clinical stage I-Ⅲ(Version 7.0). 
3. Survival information available. Surgery date 2006.1-2008.10, visit date 2013.9. Being followed up for 4.8-6.8 years. (76 cases overlapped with HEso-Squ172Sur-01 )
4. follow up updated 2015.07   

HEso-Squ180Sur-02

1.5mm

180

90

1. Esophagus squamous cell carcinoma (90 cases), 85 cases have tumor (1 core/case) and matched normal adjacent tissue (1 core/case).   
2. Clinical stage I-Ⅲ(Version 7.0). 
3. Survival information available. Surgery date 2009.1-2010.12, visit date 2013.9. Being followed up for 2.8-4.7 years. (51 cases overlapped with HEso-Squ172Sur-01 )

HEso-Squ180Sur-03

1.5mm

180

90

1. Esophagus squamous cell carcinoma (90 cases),  90 cases have tumor (1 core/case) and matched normal adjacent tissue (1 core/case). 
2. Clinical stage I-Ⅲ (Version 7.0). 
3. Survival information available. Surgery date 2009.1-2010.12, visit date 2014.9. Being followed up for 4.8-6.7 years 
4. follow up updated  2015.07

OD-CT-DgEso01-004

1.5mm

184

92

1. Esophagus squamous cell carcinoma (92 cases), tumor (1 core/case) and matched normal adjacent tissue (1 core/case). 
2. Clinical stage I-IV (Version 7.0).  
3.  
60% cases have TNM detail information.
4.  Pathology grade 1, 2, 3.

OD-CT-DgEso02-001

2.0mm

32

32

1. Esophagus squamous cell carcinoma (32 cases), 1 core/case. 
2. Pathology grade 1.

OD-CT-DgEso02-002

2.0mm

32

32

1. Esophagus squamous cell carcinoma (32 cases), 1 core/case.  
2. 
Pathology grade 2.

OD-CT-DgEso02-003

2.0mm

32

32

1. Esophagus squamous cell carcinoma (32 cases), 1 core/case. 
2. Pathology grade 2-3, 3.

OD-CT-DgEso03-002

2.0mm

62

31

1. Esophagus squamous cell carcinoma (31 cases), tumor (1 core/case) and matched normal adjacent tissue (1 core/case).  
2. 
Clinical stage II, III, IV (Version 7.0). 
3. 60% cases have TNM detail information.  
4. 
Pathology grade 1, 1-2.

OD-CT-DgEso03-003

2.0mm

62

31

1. Esophagus carcinoma (21 cases), containing squamous cell carcinoma (9 cases),  adenocarcinoma (5 cases),  small cell carcinoma ( 6 cases) and undifferentiated carcinoma (1 case). Esophagogastric junction carcinoma (8 cases).  Gastric carcinoma (2 cases).  
2. 
Tumor (1 core/case) and matched normal adjacent tissue (1 core/case).

OD-CT-DgEso04-001

1.5mm

85

40

1. Esophagus squamous cell carcinoma (40 cases), 2 cores/case.  Normal adjacent tissue (5 cases), 1 core/case. 
2. Clinical stage I, II, III (Version 7.0). 
3. 100% cases have TNM detail information. 
4. 
Pathology grade 1, 2, 3.

OD-CT-DgEso04-002

2.0mm

90

45

1. Esophagus squamous cell carcinoma (45 cases), 2 cores/case.  
2. 
Pathology grade 1 ( 39 cases),  1-2(6 cases).

OD-CT-DgEso04-003

2.0mm

90

45

1. Esophagus squamous cell carcinoma (45 cases), 2 cores/case. 
2.  Pathology grade 2. 

OD-CT-DgEso04-004

2.0mm

90

45

1. Esophagus squamous cell carcinoma (45 cases), 2 cores/case.  
2. 
Clinical stage II, III, IV (Version 7.0).
3.  50% cases have TNM detail information.
4.  Pathology grade 2-3, 3.

OD-CT-DgEso04-005

2.0mm

90

45

1. Esophagus squamous cell carcinoma (45 cases), 2 cores/case. 
2.  Pathology grade 2. 

OD-CT-DgEso04-006

2.0mm

90

45

1. Esophagus squamous cell carcinoma (45 cases), 2 cores/case. 
2. Clinical stage II, III (Version 7.0).
3. 60% cases have TNM detail information.  
4.  Pathology grade 2. 

OD-CT-DgEso04-007

2.0mm

90

45

1. Esophagus squamous cell carcinoma (45 cases), 2 cores/case. 
2.  Pathology grade 1, 1-2, 2, 2-3, 3.

OD-CT-DgEso04-008

2.0mm

90

45

1. Esophagus squamous cell carcinoma (45 cases), 2 cores/case.  
2. 
Clinical stage II, III, IV (Version 7.0). 
3.  70% cases have TNM detail information.
4.  Pathology grade 1, 1-2, 2.

OD-CT-DgEso04-009

2.0mm

45

45

1. Esophagus squamous cell carcinoma (45 cases), 1 core/case.  
2. 
Pathology grade 1, 2, 3.